top of page

The Essentials of Structured Product Labeling

Writer: Alok Naik, MS- Regulatory Affairs
Alok Naik, MS- Regulatory Affairs
16 hours ago
4 min read

When exporting drugs or biologics — including OTC drugs and pharmaceuticals — to the United States, understanding FDA requirements is critical. One key regulatory element is structured product labeling (SPL). SPL is the FDA’s standardized electronic format for submitting drug listing information, and it standardizes how product information reaches the FDA, ensuring clarity, consistency, and compliance. Navigating SPL can be complex, but mastering its essentials will help you avoid costly delays and regulatory issues.


This guide breaks down what you need to know about structured product labeling, focusing on practical steps, regulatory references, and compliance tips tailored for foreign manufacturers and exporters.


What Is Structured Product Labeling and Why It Matters


Structured product labeling is an FDA-mandated format for submitting product information electronically. It uses XML (Extensible Markup Language) to organize data such as ingredients, usage instructions, warnings, and manufacturer details. The FDA requires SPL for drugs and biologics. SPL does not apply to cosmetics or food products, which follow separate FDA registration and listing systems.


The key regulation governing SPL for drugs is 21 CFR Part 207. This rule specifies the format and content requirements for drug registration and listing submissions, which are filed in SPL format through the FDA’s electronic Drug Registration and Listing System (eDRLS).


Why does this matter to you? Because submitting your product labeling in the correct SPL format is mandatory for FDA drug listing. Failure to comply can result in product holds, import refusals, or enforcement actions.


Example: If you are exporting an OTC drug, your label must be submitted in SPL format to the FDA’s electronic Drug Registration and Listing System (eDRLS). This submission must include all required sections such as Drug Facts, active ingredients, and manufacturer contact information.


Eye-level view of a computer screen displaying XML code for product labeling
Eye-level view of a computer screen displaying XML code for product labeling

Key Components of Structured Product Labeling for Exporters


Understanding the structure of SPL files helps you prepare compliant submissions. An SPL document typically includes:


  • Header Information: Product name, NDC (National Drug Code) labeler code, and submission date.

  • Product Description: Dosage form, strength, and packaging details.

  • Ingredients: Active and inactive ingredients with quantities.

  • Usage Instructions: Indications, dosage, administration routes.

  • Warnings and Precautions: Safety information required by FDA.

  • Manufacturer Details: Facility name, address, and U.S. Agent contact.

  • Marketing Status: Whether the product is prescription or OTC.



Each section must follow FDA’s XML schema precisely. For example, the NDC labeler code is assigned by the FDA and must be included in the SPL header. If you do not have an NDC code, you must obtain one before submitting your SPL.


Actionable Tip: Work with a trusted U.S. Agent who can assist with obtaining your NDC labeler code and ensure your SPL files meet FDA formatting requirements. This step is essential for foreign companies without a physical U.S. presence.


How to Prepare and Submit SPL Files to the FDA


The SPL submission process involves several critical steps:


  1. Obtain a Labeler Code: Apply for an NDC labeler code through the FDA’s Labeler Code Request system.

  2. Create the SPL Document: Use SPL authoring tools or professional services to generate the XML file.

  3. Validate the SPL File: Run the file through FDA’s SPL validation tools to check for errors.

  4. Submit via eDRLS: Upload the validated SPL file to the FDA’s electronic Drug Registration and Listing System.

  5. Confirm Acceptance: Monitor the FDA system for acceptance or rejection notices.


Listing information must be kept current. Under 21 CFR 207.57, drug listing updates are submitted each June and December, and labeling changes are reported in those update cycles. Missing an update cycle can lead to compliance issues.



Close-up view of a person reviewing FDA submission guidelines on a tablet
Close-up view of a person reviewing FDA submission guidelines on a tablet

Common Challenges and How to Avoid Them


Many foreign exporters struggle with SPL compliance due to:


  • Complex XML Formatting: The FDA’s SPL schema is detailed and unforgiving. Small errors can cause rejections.

  • Labeler Code Confusion: Without a proper NDC labeler code, submissions cannot be processed.

  • U.S. Agent Requirements: The FDA requires a legally designated U.S. Agent for foreign companies. This agent acts as your official contact for FDA communications.

  • Timely Updates: Label changes must be reported promptly to avoid enforcement actions.


To avoid these pitfalls:


  • Engage a knowledgeable U.S. Agent who understands FDA SPL requirements and deadlines.

  • Use professional SPL authoring services to ensure your XML files are error-free.

  • Maintain an internal compliance calendar to track labeling updates and submission deadlines.

  • Regularly review FDA guidance documents such as the SPL Implementation Guide and 21 CFR Part 207.



Leveraging Structured Product Labeling Services for Compliance


Given the technical and regulatory complexity, many companies rely on specialized structured product labeling services to manage their FDA submissions. These services provide:


  • Expert preparation of SPL files according to FDA standards.

  • Assistance with obtaining NDC labeler codes.

  • Coordination with your U.S. Agent for timely submissions.

  • Ongoing compliance monitoring and updates.


Using such services reduces risk and frees your team to focus on product development and market expansion.


Note: Axentra’s pricing is flat and published. U.S. Agent service for food facility registration, including dietary supplement facilities, is $249 per facility per year, filing included. For cosmetics, U.S. Agent service is $249 per year, and MoCRA product listings are $99 for a single listing or $69 each for five or more. SPL preparation for drug listings is $149 for a single listing or $99 each for five or more.


Staying Ahead of FDA Compliance Changes


FDA regulations evolve, and staying current is essential. FDA announces changes to SPL requirements, validation rules, and submission procedures through guidance documents and Federal Register notices, and those changes can affect how your labeling information must be prepared and filed.


Regularly consult FDA updates and work with compliance experts to adapt your SPL submissions and labeling practices accordingly.



Mastering structured product labeling is a critical step for foreign companies exporting to the U.S. market. By understanding the regulatory framework, preparing accurate SPL files, and leveraging expert services, you can ensure smooth FDA compliance and successful product entry.


For detailed assistance with your SPL submissions and FDA compliance needs, consider partnering with a trusted U.S. Agent and SPL service provider who can guide you through every step of the process.

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating

Stay in the know

Join our email list and get access to important updates curated only for  our subscribers.

bottom of page